Product Information
LESCOL XL 80 MG TABLET is a brand product labeled by Sandoz Inc., priced at $13.0643 per EA under NDC 66758021131. Its NADAC has been published 78 times since Oct 9, 2024.
FDA first approved this application on Oct 6, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
80 mg/1
Manufacturer
Sandoz Inc.NDC
66758021131
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
FLUVASTATIN SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021192FDA Approved
10/6/2000
TE Code
AB
On Market Since
10/6/2000
Pharmacological Classes
Price Statistics
The NADAC for LESCOL XL 80 MG TABLET has been published 78 times since Oct 9, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.0643 per EA |
|---|---|
| All-time high | $13.1055 (Apr 16, 2025) |
| All-time low | $13.0623 (Nov 19, 2025) |
| 52-week high | $13.0681 |
| 52-week low | $13.0623 |
| Median price | $13.0643 |
| Average price | $13.0791 |
| Largest weekly change | -0.3% (Oct 22, 2025) |
| Weeks tracked | 78 |
| Tracking since | Oct 9, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 78% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluvastatin sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LESCOL XL 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LESCOL XL 80 MG TABLET, manufactured by Sandoz Inc., is $13.0643 per EA (NDC 66758021131), effective Sep 30, 2026.
How has the price of LESCOL XL 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for LESCOL XL 80 MG TABLET has held within roughly two percent of its current level. It has been tracked across 78 weekly CMS publications since Oct 9, 2024.
What are the highest and lowest recorded NADAC prices for LESCOL XL 80 MG TABLET?
Since Oct 9, 2024, the NADAC for LESCOL XL 80 MG TABLET has ranged from a low of $13.0623 (Nov 19, 2025) to a high of $13.1055 (Apr 16, 2025), with a median of $13.0643 per EA.
Are there cheaper alternatives to LESCOL XL 80 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUVASTATIN ER 80 MG TABLET, is $2.8793 per EA — about 78% below LESCOL XL 80 MG TABLET.
Who manufactures LESCOL XL 80 MG TABLET?
LESCOL XL 80 MG TABLET (NDC 66758021131) is labeled by Sandoz Inc., and CMS classifies it as a brand product.